- Home
- INVA vs EFC Comparison
INVA vs EFC Comparison
Compare INVA & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- EFC
- Stock Information
- Founded
- INVA 1996
- EFC 2007
- Country
- INVA United States
- EFC United States
- Employees
- INVA N/A
- EFC N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- EFC Real Estate
- Sector
- INVA Health Care
- EFC Finance
- Exchange
- INVA Nasdaq
- EFC Nasdaq
- Market Cap
- INVA 1.1B
- EFC 1.1B
- IPO Year
- INVA 2004
- EFC 2010
- Fundamental
- Price
- INVA $18.08
- EFC $13.10
- Analyst Decision
- INVA Buy
- EFC Buy
- Analyst Count
- INVA 1
- EFC 5
- Target Price
- INVA N/A
- EFC $13.69
- AVG Volume (30 Days)
- INVA 436.3K
- EFC 949.2K
- Earning Date
- INVA 03-07-2025
- EFC 02-27-2025
- Dividend Yield
- INVA N/A
- EFC 11.91%
- EPS Growth
- INVA 46.55
- EFC 21.68
- EPS
- INVA 0.99
- EFC 1.32
- Revenue
- INVA $352,745,000.00
- EFC $290,293,000.00
- Revenue This Year
- INVA $16.20
- EFC N/A
- Revenue Next Year
- INVA N/A
- EFC $26.40
- P/E Ratio
- INVA $18.25
- EFC $9.96
- Revenue Growth
- INVA 21.46
- EFC 12.72
- 52 Week Low
- INVA $14.33
- EFC $10.88
- 52 Week High
- INVA $21.28
- EFC $13.46
- Technical
- Relative Strength Index (RSI)
- INVA 45.13
- EFC 71.01
- Support Level
- INVA $17.92
- EFC $12.56
- Resistance Level
- INVA $18.20
- EFC $13.12
- Average True Range (ATR)
- INVA 0.26
- EFC 0.15
- MACD
- INVA -0.04
- EFC 0.04
- Stochastic Oscillator
- INVA 33.33
- EFC 85.28
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About EFC Ellington Financial Inc.
Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.